Aortic Aneurysm Market Size, Share & Trends Analysis Report By Type (TAA, AAA), By Treatment (OSR, EVAR), By Product (Stent Grafts, Catheters), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Research Methodology

A three-pronged approach was followed for deducing the aortic aneurysm market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for aortic aneurysm market to gather the most reliable and current information possible.

• We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
• We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
• We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
• We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
• We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of aortic aneurysm market data depending on the type of information we’re trying to uncover in our research.

• Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

• Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

• Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

• Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

• Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

• Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

• This step also entails the finalization of the report scope and data representation pattern.

• Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Aortic Aneurysm Market Categorization:

The aortic aneurysm market was categorized into five segments, namely type (Thoracic Aortic Aneurysm, Abdominal Aortic Aneurysm), treatment (Open Surgical Repair, Endovascular Aneurysm Repair), product (Stent Grafts, Catheters), end-use (Hospitals, Ambulatory Surgery Centers, Clinics), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The aortic aneurysm market was segmented into type, treatment, product, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

• Demand estimation of each product across countries/regions summed up to from the total market.

• Variable analysis for demand forecast.

• Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

• Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

• Used extensively for new product forecasting or analyzing penetration levels.

• Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

• Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

• This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The aortic aneurysm market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into sixteen countries, namely, the U.S.; Canada; the UK.; Germany; France; Italy; Spain; Japan; China; India; Australia; South Korea; Brazil; Mexico; South Africa; Saudi Arabia.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Aortic aneurysm market companies & financials:

The aortic aneurysm market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

• MEDTRONIC PLC, Medtronic plc is the successor of Medtronic, Inc., a Minnesota corporation. Medtronic is one of the largest providers of medical technology, solutions, and services provider for relieving pain and health restoration. The company focuses on three main aspects of business, which are therapy innovation, global presence especially targeting emerging markets, and economic value with cost-effective treatment options. It mainly targets hospitals, clinics, institutes, healthcare providers, distributors, government healthcare programs, and Group Purchase Organizations (GPOs). The company operates through four business units- cardiac and vascular groups, minimally invasive therapies, restoration therapies, and diabetes, of which the cardiac and vascular group offers a broad product line for an aortic aneurysm.

• TERUMO CORPORATION, Terumo Corporation is involved in the development, manufacture, export, import, as well as marketing of medical devices, supplies, and accessories. It also deals in interventional systems and veterinary care products. The company is involved in providing pharmaceutical solutions and infusion devices. The company operates through three business segments cardiac and vascular company, general hospital company, and blood Management Company. The cardiac and vascular company namely Terumo Cardiovascular Group offers products to treat an aortic aneurysm. In the U.S. market, Terumo Cardiovascular Group provides its vascular grafts manufactured by the subsidiary of Terumo Corporation named Vascutek Ltd. Outside the U.S. market, the company distributes its products through a strong network of distributors and via direct sales operations.

• MICROPORT SCIENTIFIC CORPORATION, Microport Scientific Corporation and its subsidiaries is a medical device company based out of Shanghai. The company specializes in interventional cardiology, surgical management, interventional radiology, electrophysiology, orthopedics, diabetes, and endocrine management, and others. MicroPort has a broad product portfolio of around 200 approved products which are being distributed in 5,000+ hospitals across 80 countries. The company operates in four business areas namely orthopedics, cardiovascular, endovascular, and electrophysiology business. The endovascular business unit is involved in the development of products for abdominal aortic aneurysms and thoracic aortic aneurysms.

• W.L. GORE & ASSOCIATES INC, W.L. Gore & Associates Inc. (Gore) is a manufacturer of several advanced technology products for the electronics, industrial, fabrics, and medical markets. Gore Medical, part of W.L. Gore & Associates, manufactures vascular grafts, endovascular and interventional devices, surgical meshes, sutures, and staple line reinforcement materials to be used by healthcare professionals in hospitals. The company’s medical portfolio comprises implant biomaterials, membranes for venting and filtration, and unique cable and tubing products. It provides products and solutions such as endovascular stent grafts, synthetic vascular grafts, bioabsorbable devices, and interventional devices, to be used in hernia repair and sutures used in vascular, cardiothoracic, general surgery, and orthopedic procedures. Its vascular products such as GoreTex Vascular Grafts are used in a range of vascular procedures Gore operates in more than 25 countries with manufacturing facilities in the U.S., Germany, the UK, China, and Japan.

• COOK MEDICAL, Cook Medical is a part of Cook Group and distributes its products in around 135 countries with hospitals and doctors being its target customers. The company has a broad product portfolio including Zenith thoracic product portfolio, Zenith visceral product portfolio, Zenith abdominal product portfolio, and Zenith endovascular accessories.

• JOTEC (CRYOLIFE, INC.), JOTEC, a fully owned subsidiary of Cryolife, Inc., develops, manufactures, and markets medical devices for aortic and peripheral vascular disease as well as mechanical heart valves, surgical adhesive, mitral chordal replacement products, and a polysaccharide hemostatic system. JOTEC has a broad portfolio of endovascular products for aortic repair which include highly differentiated products, such as the E-xtra DESIGN ENGINEERING, a portfolio of stent grafts custom designed for a patient’s anatomy for TAAA repair, the E-liac for the repair of aneurysms in the iliac arteries, and less differentiated products, including the Evita THORACIC 3G for TAA repair.

Value chain-based sizing & forecasting

Supply Side Estimates

• Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

• Segment revenue determination via variable analysis and penetration modeling.

• Competitive benchmarking to identify market leaders and their collective revenue shares.

• Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

• Identifying parent markets and ancillary markets

• Segment penetration analysis to obtain pertinent

• revenue/volume

• Heuristic forecasting with the help of subject matter experts

• Forecasting via variable analysis

Aortic Aneurysm Market Report Objectives:

• Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

• Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

• Understanding market estimates and forecasts (with the base year as 2022, historic information from 2016 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Aortic Aneurysm Market Report Assumptions:

• The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

• The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

• We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

• All market estimates and forecasts have been validated through primary interviews with the key industry participants.

• Inflation has not been accounted for to estimate and forecast the market.

• Numbers may not add up due to rounding off.

• Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

• Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

• Latin America includes Central American countries and the South American continent

• Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

• Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

• Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.